Cargando…

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART

INTRODUCTION: After achieving undetectable HIV-RNA on cART, on cessation, HIV-RNA rebounds to pre-treatment values for the majority due to the presence of an inaccessible viral reservoir. There is some evidence that cART during primary HIV infection (PHI) limits the reservoir size, optimizing the ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fidler, Sarah, Olson, Ashley, Fox, Julie, Phillips, Andrew, Morrison, Charles, Thornhill, John, Bucher, Heiner, Muga, Roberto, Porter, Kholoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P288
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225245/ https://www.ncbi.nlm.nih.gov/pubmed/25397564 http://dx.doi.org/10.7448/IAS.17.4.19820

Ejemplares similares

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection
por: Fidler, Sarah, et al.
Publicado: (2017)

Comparing Outcomes of COVID-19 vs NonCOVID-19 Lung Transplant Recipients on ECMO as a Bridge to Transplant
por: Pasupneti, S., et al.
Publicado: (2022)

Prise en charge des patients atteints de pneumonie COVID-19 sévère à critique hors réanimation
por: Kaabi, L., et al.
Publicado: (2022)

MEMRI study - feedback of MEMS dosing history improves adherence to long-term HAART: adherence is associated with incidence of ‘blips’ in viral load
por: White, D, et al.
Publicado: (2012)

1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure
por: Fleit, Madeline, et al.
Publicado: (2023)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
por: Parsons, Victoria, et al.
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)

Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients: role of cART and gender
por: Suardi, Elisa, et al.
Publicado: (2014)

Clinical and socio-demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART-1
por: Daniel Labhardt, Niklaus, et al.
Publicado: (2014)

Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection
por: Crowell, Trevor A, et al.
Publicado: (2020)

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study
por: Farmer, Aaron, et al.
Publicado: (2016)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Service impact of a change in HIV-1 viral load quantification assay
por: Tipple, Craig, et al.
Publicado: (2014)

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study
por: Labhardt, Niklaus Daniel, et al.
Publicado: (2014)

Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
por: Rong, Libin, et al.
Publicado: (2009)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Early clinical response and presence of viral resistant minority variants: a proof of concept study
por: Callegaro, Annapaola, et al.
Publicado: (2014)

Long-term effect of a four-drugs induction regimen for patients with high baseline viral load
por: Maggiolo, Franco, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
por: Conway, Jessica M., et al.
Publicado: (2011)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
por: Sörstedt, Erik, et al.
Publicado: (2016)

1713. Factors Associated with Viral Rebound post Blip in Patients from a Community HIV Clinic
por: Sanchez, Eduardo, et al.
Publicado: (2020)

Viral Blips Were Infrequent in HIV-1-Infected Virologically-Suppressed Adults Treated with Tenofovir Alafenamide or Tenofovir DF Rilpivirine-Containing Regimens
por: Wohl, David A, et al.
Publicado: (2017)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Switching to nevirapine-based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity
por: Patterson, Patricia, et al.
Publicado: (2014)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

Les éruptions virales aux urgences dermatologiques : étude comparative avant et après la pandémie COVID-19
por: Ben Kahla, Marouane, et al.
Publicado: (2021)

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

1561 The Relationship Between Self-reported Adherence and Efavirenz Blood Levels on the Appearance of HIV Viral Load Blips
por: Farmer, Aaron, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_86j4ks73f3kjgo4oqnesejkqrt